25 May 2013
Keywords: autoimmune, shares, tumble, myloral, fails, ph, iii
Article | 24 April 1997
The eager wait for the results of AutoImmune's Phase III trial ofMyloral (myelin basic protein) for the treatment of multiple ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 April 1997
5 May 1997
24 May 2013
© 2013 thepharmaletter.com